Viewing nowCombinationNPFozine 5/80 mg
Valsartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.

MFDS item code 201400702 · Approved 2014.02.17 · Insurance code 669905910
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or valsartan. It effectively lowers blood pressure and helps reduce the risk of cardiovascular complications.
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose.
Under 18 years of age: Administration of this medicine is not recommended because its safety and efficacy have not been established in pediatric patients under 18 years of age.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy. Therefore, it should be discontinued immediately if pregnancy is confirmed. Individuals with allergies to the active ingredients of this drug or similar drugs, pregnant women, women who may become pregnant, and nursing mothers should not use this medication. Patients with severely impaired renal or hepatic function, those with specific heart diseases or vascular-related conditions should also avoid using this drug. Patients with a deficiency of fluids or sodium in the body should stabilize their condition before taking this medication, and blood pressure and condition should be closely monitored during treatment. Patients with high potassium levels need to be cautious when taking this medication along with potassium-containing drugs or supplements, and should have their potassium levels checked frequently. Patients with renal vascular issues may be affected in their kidney function while taking this medication, so regular check-ups are necessary. Patients with heart failure or those who have had a myocardial infarction should closely monitor changes in kidney function and blood pressure while on this medication, and may need dosage adjustments as warranted. This medication may rarely cause side effects such as headache, dizziness, swelling, hypotension, and skin rash. If symptoms are severe, consultation with healthcare professionals is necessary. Caution is advised when driving or operating machinery due to possible dizziness or fatigue. There may be interactions when taken alongside other antihypertensive drugs or certain medications, so it is crucial to inform healthcare professionals about any medications being taken. It is recommended that pregnant or nursing women avoid using this medication and consult healthcare professionals if planning for pregnancy. The safety of this drug for children has not been sufficiently established, hence it is not advisable for use in individuals under 18 years of age. In cases of overdose, severe hypotension or cardiac issues may occur, so it is essential to adhere to prescribed dosages and seek immediate medical attention if any unusual symptoms arise.
pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbance, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, rash, itching, joint swelling, back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, anasarca, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory loss, taste disturbance, peripheral neuropathy, excessive muscle tension, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, phototoxic reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neurosensitivity, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius.
Dark yellow round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.